The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

US STOCKS-Wall St up for sixth straight session on earnings, healthcare

Tue, 22nd Apr 2014 20:24

* S&P 500, Nasdaq on six-day winning streak

* Netflix up after results; Facebook gains on upgrade

* Allergan soars as Ackman and Valeant bid for company

* Indexes up: Dow 0.4 pct, S&P 0.41 pct, Nasdaq 0.97 pct (Updates to close)

By Chuck Mikolajczak

NEW YORK, April 22 (Reuters) - U.S. stocks rose on Tuesdayas a host of solid earnings reports, along with strength in thehealthcare sector, helped lift the S&P 500 and Nasdaq to theirsixth straight advance.

Netflix Inc surged 7 percent to $372.90 a day aftershowing strong subscriber growth, a sign the trading favoritestill had room to grow despite recent concerns over itsvaluation. With the day's gain, the stock moved to the plus sidefor the year after a 21 percent drop in March.

Healthcare, up 1 percent, was the best performingof the 10 major S&P sectors. Allergan Inc jumped 15.2percent to $163.65 a day after activist investor William Ackmanteamed up with Canadian drugmaker Valeant PharmaceuticalsInternational Inc to bid for the company. U.S.-listedValeant shares gained 7.5 percent to $135.41.

Also providing support to the sector was a deal betweenNovartis and GlaxoSmithKline, in which the twotraded over $20 billion worth of assets in an effort to copewith healthcare spending cuts and generic competition.U.S.-listed shares of Novartis gained 1.3 percent to$85.56, while Glaxo advanced 4.1 percent to $55.30.

Better-than-expected earnings have lifted equities recently,though companies have largely been exceeding reduced forecasts.Profits are seen rising 1.1 percent this quarter, down from the6.5 percent growth rate estimated at the start of the year.

"What was baked into the market, in spite of a market nearan all-time high, was a sloppy earnings season," said MikeSerio, regional chief investment officer for Wells Fargo PrivateBank in Denver.

"We've had some really good beats at this point, we've had acouple of good announcements today, you throw on the M&Aactivity in the drug sector, at least in the short term,everybody looks pretty excited about this market."

Dow components Travelers Cos Inc and UnitedTechnologies Corp both beat expectations, and UnitedTech raised the low end of its full-year profit outlook. Sharesof Travelers rose 0.6 percent to $86.89 while United Tech added0.8 percent at $119.19.

McDonald's Corp reported earnings that fellalongside a drop in U.S. same-store sales, and its sharesslipped 0.4 percent to $99.32.

With 20 percent of the S&P having reported through Tuesdaymorning, 63 percent have topped earnings expectations, accordingto Thomson Reuters data, matching the long-term average. On therevenue side, 51 percent have exceeded forecasts, below the 61percent long-term average.

The Dow Jones industrial average rose 65.12 points or0.4 percent, to 16,514.37, the S&P 500 gained 7.66 pointsor 0.41 percent, to 1,879.55 and the Nasdaq Composite added 39.912 points or 0.97 percent, to 4,161.458.

In another positive sign for equities, the Dow JonesTransportation average, up 0.6 percent, closed at itsfirst record high since April 2. The index got a boost fromairlines such as United Continental Holdings, up 4.6percent, and Alaska Air Group Inc, up 1.3 percent, whichmoved higher on a 2-percent drop in oil prices.

Facebook Inc shares rose 2.9 percent to $63.03 andhelped boost the Nasdaq 100 and S&P 500. Credit Suisseupgraded the social networking company to "outperform" on higherexpectations for the company's long-term average revenue peruser.

Volume was light, with about 5.71 billion shares traded onU.S. exchanges, below the 6.7 billion average so far this month,according to data from BATS Global Markets.

Advancing stocks outnumbered declining ones on the NYSE by2,226 to 811, while on the Nasdaq, advancers beat decliners1,900 to 727. (Reporting by Chuck Mikolajczak; Editing by Nick Zieminski)

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.